March 27 (Reuters) - Imprimis Pharmaceuticals Inc:
* IMPRIMIS PHARMACEUTICALS ISSUED COMPOSITION PATENT FOR NON-OPIOID CONSCIOUS SEDATION FORMULATION
* IMPRIMIS PHARMACEUTICALS INC - SECURED A PATENT COVERING COMPANY’S MKO MELT COMPOUNDED FORMULATION Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)